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Abstract
MicroRNAs (miRNAs) are short 20–22 nucleotide RNA molecules that act as negative regulators of gene expression via
translational repression: they have been shown to play a role in development, proliferation, stress response, and apoptosis.
The transcriptional regulator LRF (Leukemia/lymphoma Related Factor) has been shown to prevent p19ARF transcription
and consequently to inhibit senescence in mouse embryonic fibroblasts (MEF). Here we report, for the first time, that LRF is
post-transcriptionally regulated by miR-20a. Using a gene reporter assay, direct interaction of miR-20a with the LRF 39UTR is
demonstrated. To validate the interaction miR-20a/39UTR LRF miR-20a was over-expressed, either by transient transfection
or retroviral infection, in wild type mouse embryo fibroblasts and in LRF-null MEF derived from LRF knock-out mice. We
observed LRF decrease, p19ARF increase, inhibition of cell proliferation and induction of senescence. The comparison of
miR-20a activity in wt and LRF-null MEF indicates that LRF is the main mediator of the miR-20a-induced senescence and that
other targets are cooperating. As LRF down-regulation/p19ARF induction is always accompanied by E2F1 down-regulation
and increase of p16, we propose that all these events act in synergy to accomplish miR-20a-induced senescence in MEF.
Senescence has been recently revaluated as a tumor suppressor mechanism, alternative to apoptosis; from this point of
view the discovery of new physiological ‘‘senescence inducer’’ appears to be promising as this molecule could be used as
anticancer drug.
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Introduction
Pok proteins are a group of bifunctional proteins with potential
oncogenic properties. They consist of an N terminal Poz domain
and a C terminal kruppel-type (C2H2) zinc finger domain. The C-
terminal zinc finger mediates specific DNA recognition and
binding, while the amino-terminal POZ domain recruits histone
deacetylase repressing transcription [1]. The oncogenic members
of the Pok family include PLZF (Promyelocytic Leukemia Zinc
Finger), whose t(11:17) translocation is at the basis of acute
promyelocytic leukaemia, [2,3] and BCL-6 (B cell Lymphoma 6),
which is deregulated in many types of lymphoma [4]. Another
member of the family is LRF (Leukemia/lymphoma Related
Factor) encoded by the zbtb7a gene and localized on chromosome
19p13.3 which is a hot spot for chromosomal translocations in
human tumors. This protein, already known to have pleiotropic
functions during embryogenesis [5,6,7], has recently been shown
to act as an oncogene. When LRF is over-expressed in B and T
lymphoid lineages (lckEm-LRF), mice develop aggressive lympho-
mas that cause death between 9 and 40 weeks of age [8]. Like the
other members of the family, LRF is a transcriptional repressor
and p19ARF has recently been found to be a specific target in
MEF [9]. p19ARF oncosuppressor is known as a key mediator of
cell senescence. It mainly acts by inhibiting MDM2 and in turn
up-regulating p53 levels [10]. LRF over-expression keeps p19ARF
level down,preventing the onset of the senescence program and
allowing single oncogenic proteins such as Ras to transform MEF
[9].
Although it has been shown that LRF is over-expressed in some
human cancers [8], little is known about the mechanisms causing
its up-regulation.
MicroRNAs (miRNAs) have recently come into focus as a novel
class of post-transcriptional regulatory elements. They are
abundant endogenous ,22-nucleotides (nt) RNAs that repress
mRNA translation by base pairing to 39UTR sequences [11]. The
miRNA-target recognition is mainly due to the perfect comple-
mentarity between a short 7–8 nt stretch at 59 end of the miRNA
molecule (miRNA seed) and the corresponding stretch on the
39UTR of the target gene (seed match). This results in a reduced
translation and in turn a decreased level of the protein [12].
Some of the most studied microRNAs involved in human
cancer are those belonging to miR-17-92 cluster. This cluster is
located in a region amplified in lymphoma [13,14] and lung
cancers [15] while in other types of cancer, including nasopha-
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ryngeal carcinoma [16,17], hepatocellular carcinoma [18] and
breast cancer [19], the genomic location of the miR-17-92 cluster
undergoes loss of heterozygosity suggesting that it may behave
both as oncogene and oncosuppressor.
Enforced expression of the miR-17-92 cluster along with c-Myc
expression accelerates tumor development in a mouse B-cell
lymphoma model [13]. The underlying mechanism of action
appears to be the E2F1 down-regulation by two members of the
cluster, miR-17 and miR-20a. This c-Myc/miR-17-92 circuit
helps to maintain E2F1 protein level below a pro-apoptotic
threshold and cell proliferation prevails [20,21,22,23].
On the other hand, in breast cancer cells the most relevant target
of miR-17 is not E2F1, but AIB1. The nuclear receptor coactivator,
amplified in breast cancer 1 (AIB1), acts as an oncogene. It actually
enhances the transcriptional activity of many transcription factors,
among which the estrogen receptor. Indeed, when miR-17 is over-
expressed in breast cancer cells, a big decrease in ER-mediated
signaling and in turn proliferation is observed and cells loose their
ability to form colonies in soft agar [24].
Here, we report a novel activity exerted by miR-20a in mouse
embryonic fibroblasts (MEF). This microRNA is able to control
LRF protein at the post-transcriptional level and, when over-
expressed, it induces premature senescence. This effect appears to
be due to p19ARF up-regulation accompanied by up-regulation of
p16 and down-regulation of E2F1.
Results
We utilized early passages MEF, known to express LRF [9], to
investigate whether this anti-senescence gene is regulated by
miRNAs.
miR-20a regulates LRF protein at the post-transcriptional
level
In silico analysis with TargetScanS (http://genes.mit.edu/
targetscan/) indicated various miRNA families potentially targeting
the mouse zbtb7a 39UTR. We focused our attention on the miR-17
family whose members are reported in Figure 1a [25]. Before testing
if mouse zbtb7a 39UTR interacts with miR-17 family members, the
expression of representative members of the family was ascertained
by RT-PCR. As reported in Figure 1b, MEF express the precursor of
miR-20a, miR-17 and miR-106b, while they do not express the
precursor of miR-106a. We then tested whether mouse zbtb7a
39UTR interacts with miR-20a, miR-17 and miR-106b, using an
EGFP reporter assay. miRNA-expressing plasmids (p-miRs) were
investigated for their ability to inhibit fluorescence and it was found
that p-miR-20a (Figure 1d), p-miR-17 (Figure 1e) and p-miR-106b
(Figure 1f) all inhibit in a dose dependent manner.
Since we decided to focus on miR-20a throughout the
experiments, the presence of the mature form in MEF cells was
first ascertained by Northern blot (Figure 1c). To demonstrate the
direct interaction, we again used the EGFP reporter assay. p-miR-
20a was tested against p-zbtb7a 39UTR wild type or mutated at
the two binding sites specific for miR-17 family. p-miR-20a/
p-zbtb7a 39UTR interaction reduced the fluorescence, while
p-miR-20a/p-zbtb7a 39UTRm interaction rescues the inhibition
(Figure 1g) indicating that miR-20a binds directly zbtb7a
39UTR.
Gain and loss of functions experiments were then performed.
We observed that miR-20a over-expression, by transfection of
80 nM mature miR-20a, reduces LRF protein by 40% (Figure 1h).
Conversely, inhibition of endogenous miR-20a by transfection
with 80 nM antisense 29-O-methyl-oligoribonucleotide (decoy, d-
20a) increases LRF protein level by 55% (Figure 1i).
miR-20a over-expression induces p19ARF
LRF has been shown to be a specific transcriptional repressor of
p19ARF [9]. The transient over-expression of miR-20a shows that
48 hours post transfection the level of LRF mRNA was almost
unchanged, while it was reduced following a si-RNA specific for
LRF, si-LRF, (Figure 2a). p19ARF was more strongly up-
regulated by si-LRF than by miR-20a at both the mRNA
(Figure 2a) and protein (Figure 2b,c) levels in agreement with the
degree of LRF inhibition. Downstream of p19ARF, p53
expression level was slightly increased while p21 level remained
similar to control cells (Figure 2b,c).
miR-20a over-expression decreases cell proliferation and
induces senescence
The p19ARF up-regulation is known to inhibit MEF proliferation
and to trigger senescence [9]. For this reason we investigated the
effect of miR-20a on these two biological end points in MEF at early
passages. MEF transfected with miR-20a proliferated less than those
transfected with control miRNA (Figure 3a). To evaluate senescence,
the number of SA-b-gal positive and binucleated cells was
determined 96 hours post transfection. miR-20a significantly
enhanced SA-b-gal positive (Figure 3b) and binucleated (Figure 3c)
cells over control level. It can be noted that si-LRF was less efficient
than miR-20a despite the stronger induction of p19ARF.
To reinforce the finding that miR-20a induced senescence, LRF
positive and null-LRF MEF were infected with a retrovirus
expressing miR-20a (PIG/miR-20a) in order to achieve a stable
expression. The results show that PIG/miR-20a markedly inhibits
cell proliferation (Figure 3d), and it increases the percentage of SA-
b-gal positive cells two fold over control (Figure 3e). Interestingly,
PIG/miR-20a is still able to cause a statistically significant increase
in SA-b-gal positive cells in LRF-null cells (Figure 3e). These data
and data from transient trasfection experiments, showing that
miR-20a over-expression induces a greater percentage of senes-
cent cells than si-LRF (Figure 2e), indicate that although LRF is
target of miR-20a, the modulation of other targets contributes to
the senescent effect.
miR-20a over-expression affects the expression of
p16INK4a and E2F1
E2F1, which plays a crucial role in senescence, is a known
target of miR-20a. For this reason, the expression of E2F1 after
miR-20a transient over-expression in MEF or stable expression in
wild type and LRF-null MEF was determined. The results clearly
indicate that miR-20a decreases E2F1 protein level in both cases
(Figure 4 a,b). The depletion of the endogenous miR-20a with d-
20a slightly enhanced the expression of E2F1 thus confirming
that E2F1 is potentially under miR-20a control (Figure 4c).
[20,21]
We therefore asked whether E2F1 down-regulation per se
contributed to senescence. MEF were transfected with si-E2F1:
the expression of E2F1 was reduced but the reduction was not
accompained by p19ARF upregulation (Figure 4d). In agreement
with this result senescent cells were not induced (Figure 4e)
demonstrating that E2F1 down-regulation is not enough per se to
induce senescence.
We asked whether another key senescence inducer, the
tumor suppressor p16, might be induced by miR-20a over-
expression. We found that only miR-20a and not si-LRF is able
to increase p16 protein levels (Figure 5 a,b). Moreover,
transient miR-20a transfection in LRF-null MEF demonstrates
that miR-20a is able to induce p16 also in the absence of LRF
(Figure 5c).
miR-20a-Induced Senescence
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Figure 1. miR-20a regulates LRF expression in MEF. a: Sequences of miRNAs belonging to miR-17 family; b: RT-PCR analysis of pri-miRNA
expression in MEF. Total RNA was extracted and amplified by RT-PCR using appropriate primers. The PCR products of,500 bp length are pri-miRNAs
of the miR-17 family; c: Northern blot analysis of mature miR-20a expression in MEF. 20 mg of total RNA was analyzed with miR-20a probe or valine
tRNA control probe; d, e, f: Interaction between 39UTR of mmu-zbtb7a mRNA and miR-17 family. HEK293T cells were co-transfected with p-zbtb7a
39UTR and increasing concentrations of p-miR-20a, p-miR-17 p-miR-106b or p-miR-26a control plasmid. 24 hours after transfection, cells were
collected and the EGFP fluorescence intensity of each sample was determined with a FACscan analyzer. The relative expression of p-zbtb7a 39UTR was
obtained by the ratio of the mean fluorescence value of HEK293T cells transfected with p-miR-20a, p-miR-17 or p-miR-106b and the mean
fluorescence value of HEK293T cells transfected with p-miR-26a control plasmid. Each bar represents the mean6SE of three independent
experiments; g,: Transfection of p-miR-20a with either p-zbtb7a 39UTR or p-zbtb7a 39UTRm in HEK293T. Cells were collected 24 hours after
transfection and the EGFP fluorescence intensity of each sample was determined with a FACscan analyzer. The relative expression was obtained by
the ratio of the mean fluorescence values of HEK293T cells cotransfected with p-miR-20a and either p-zbtb7a 39UTR or p-zbtb7a 39UTRm normalized
to that of HEK293T cells transfected with pEGFPC1. Each bar represents the mean6SE of three independent experiments. h i: Effects of over-
expression/depletion of miR-20a on LRF expression.
doi:10.1371/journal.pone.0002542.g001
miR-20a-Induced Senescence
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Discussion
The persistent mitogenic stimulation during the propagation in
culture induces senescence in MEF [26]. Senescence is also
induced by cellular stresses such as the over-expression of single
oncogenes [27], free radicals [28], or DNA damaging drugs [29].
While the culture induced senescence occurs after 5–6 passages in
culture, the stress-induced senescence appears 48–72 hours after
the insult. The induction of both types of senescence is mediated
by the transcriptional activation of the INK4a locus and the
consequent increase of the two encoded proteins p19ARF and
p16INK4a [30,31]; p19ARF protein up-regulates p53 levels by
inhibiting MDM2 [10] while p16INK4a inhibits cyclin dependent
kinases thereby activating the retinoblastoma protein [32].
Moreover p19ARF has been reported to associate with proteins
other than MDM2 and to have p53-independent activities most of
which remain to be elucidated [30].
The transcriptional repressor LRF prevents the senescence
program in MEF by inhibiting p19ARF transcription [9]. From an
in silico analysis we found that zbtb7a 39UTR is predicted to be the
target of several miRNA families, among which is miR-17 family
(Figure 1a). Using a hybrid reporter assay, we were able to
demonstrate that miR-17 family members, in particular miR-20a,
interact directly with zbtb7a 39UTR (Figure 1d,e,f,g). We also over-
expressed miR-20a in MEF and found that LRF protein was
consistently decreased (Figure 1h), while the mRNA level was
unchanged (Figure 2a). Viceversa the depletion of the endogenous
miR-20a by the antisense d-20a increased LRF protein level
(Figure 1i). These results clearly demonstrate that in MEF LRF is
under miR-20a control.
Interestingly, we observed that the transient and stable miR-20a
over-espression direct MEF toward senescence (Figure 3b,e), more
similar to stress rather than to culture induced senescence, as it is
accomplished within few days from transfection.
It is well known that miRNAs modulate the expression of
several targets at once and in this way they activate or inhibit
pathways [33,34]. The final output depends on the fine-tuning of
different players of the pathways. The miR-20a-induced senes-
cence in MEF is not an exception to this rule. The results obtained
following the stable and transient expression of miR-20a indicate
the important role of LRF down-regulation/p19ARF up-regula-
tion, but also suggest that other targets are involved. This
assumption is based on the finding that miR-20a is a more
powerful senescence inducer than si-LRF, although it is a milder
inhibitor of LRF/inducer of p19ARF (Figure 2c) and that in LRF-
null MEF additional senescence is induced (figure 3e).
Looking for other possible miR-20a targets, we focused our
attention on E2F1, already known to be under miR-17 family
control [20,21,23]. We confirmed that, when miR-20a is over-
expressed either by transient transfection (Figure 4a) or stable
infection (Figure 4b), E2F1 is invariably decreased. Furthermore,
when endogenous miR-20a is depleted by decoy, E2F1 protein
level is slightly increased confirming that E2F1 is under miR-20a
control in MEF (Figure 4c).
The role of E2F1 in senescence is controversial. p19ARF is
under the transcriptional control of E2F1 [35] and this explains
how premature senescence can be induced by oncogenic stresses,
among which E2F1 over-expression [36]. Nonetheless, in an
E2F1-null setting, proper stimuli can still induce p19ARF and
senescence [10]. Moreover, p19ARF can in turn decrease E2F1
protein level/activity [37,38,39]. Also, in some cellular context the
down-regulation of E2F1 is a necessary prerequisite for senescence
[40,41]. In agreement with an anti-senescence role of E2F1, we
found that si-LRF transfection slightly increases MEF senescence
Figure 2. Effects of miR-20a on LRF-p19ARF pathway. a: q-RT-
PCR of LRF, p19ARF and p21. Total RNA was extracted from MEF
transfected with miR-20a, si-LRF or si-EGFP. mRNA level, detected by
Real-Time PCR, was normalized to that of GAPDH. The values are the
mean of two independent experiments. Western blot (b) and
quantification (c) of LRF, p19ARF, p53 and p21. The band intensity
was normalized to that of tubulin. Each bar represents the mean
relative expression of LRF6SE of three independent experiments.
doi:10.1371/journal.pone.0002542.g002
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and induces a decrease of E2F1 (Figure 4d), possibly p19ARF-
dependent. On the other hand miR-20a was able to induce a more
profound E2F1 down-regulation than si-LRF both in wt and in
LRF-null cells (Figure 4a,b), possibly by direct binding of this
microRNA to the 39UTR of E2F1 mRNA. These data strongly
suggest that miR-20a induced premature senescence is due to the
cooperation of LRF and E2F1 down-regulation. This hypothesis is
supported by the finding that E2F1 knock-down by si-E2F1 per se is
not enough to induce senescence (Figure 4e) and by the significant
increase of senescence in LRF-null MEF over-expressing miR-20a
concomitant with E2F1 reduction (Figure 3e). We also found that
miR-20a increases another important senescence player, p16 [42],
in both wild type (Figure 5a,b) and LRF-null MEF (Figure 5c).
Recently the p16 pathway has been shown to have a central role in
induction of premature senescence establishing an autonomous
activation of ROS production via inhibition of E2F1 activity [28].
This circuit leads at the end to a cytokinesis block due to PKC
activation [28] and a inhibition of mitotic exit network kinase,
WARTS [43,44]. Although we have not investigated these
activities, the significant induction of binucleated cells by miR-
20a (Figure 3c) and the decrease in E2F1 level are consistent with
the activation of the p16 pathway as well. LRF down-regulation
does not seem to play a role in p16 induction, because it has been
previously reported to specifically inhibit p19ARF, but not p16
transcription [9]. We observed that, as opposed to miR-20a, si-
LRF causes only p19ARF (Figure 2c) and not p16 (Figure 5a) up-
regulation. Furthermore, p16 is induced by miR-20a in both wt
(Figure 5a) and LRF-null MEF (Figure 5c). A plausible hypothesis
Figure 3. miR-20a induces senescence in MEF. Detection of cell proliferation (a), SA-ß-gal positive (b) and binucleated (c) cells in wt MEF
transfected with miR-20a. Detection of proliferation (d) and SA-ß-gal positive (e) cells in wt and LRF-null MEF retrovirally infected with PIG/miR-20a.
Each bar represents the mean6SE of three independent experiments.
doi:10.1371/journal.pone.0002542.g003
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Figure 4. miR-20a regulates E2F1. Western blot analysis showing the expression of LRF and E2F1 in wt (a) and LRF-null MEF (b) retrovirally
infected with PIG/miR-20a; c: Western blot analysis showing the expression of E2F1 in MEF transfected with d-20a; d: Western blot analysis showing
the expression of E2F1 and p19ARF in wt MEF transfected with si-LRF, si-E2F1, si-EGFP and miR-20a; e: percentage of SA-ß-gal positive cells in wt MEF
transfected with si-LRF, si-E2F1, si-EGFP and miR-20a.
doi:10.1371/journal.pone.0002542.g004
Figure 5. miR-20a regulates p16. Western blot analysis showing the expression of p16 after miR-20a transfection in wt MEF (a,b) and in LRF-null
MEF (c). Each bar represents the mean6SE of three independent experiments.
doi:10.1371/journal.pone.0002542.g005
miR-20a-Induced Senescence
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is that miR-20a directly or indirectly affects a negative regulator of
p16. In this respect, it is of note that E2F1 and c-Myc are linked by
a positive feedback loop [45,46], so that miR-20a-induced E2F1
down-regulation might decrease c-Myc level. Reduced c-Myc level
has been shown to trigger senescence by inducing p16 via Bmi-1
down-regulation [47]. In our case the concomitant downregula-
tion of E2F1 accompanied by p16 up-regulation are events which
cooperate with LRF down-regulation to induce senescence. The
combined modulation of these different proteins is likely to be at
the basis of the senescence pathways elicited by miR-20a-over-
expression.
In conclusion our data demonstrate that in MEF at early passages
miR-20a is able to induce cellular senescence. The direct down-
regulation of LRF, with the consequent induction of p19ARF, is a
key mediator of the process, but the cooperation with other
pathways, represented by E2F1 down-regulation and p16 up-
regulation, appears to contribute. The finding that miR-20a is able
to induce premature senescence is, in our opinion, interesting as it
may have potential clinical relevance as anti-tumorigenic drug.
Materials and Methods
Reagents
Ultrahyb Oligo solution (Ambion); Nylon membrane Hybond-C
extra, ECL detection kit (Amersham Biosciences); pEGFP-C1 plasmid
(Clontech); mature miR-20a, si-EGFP, si-LRF (Dharmacon); antisense
29-O-methyl-oligoribonucleotide against miR-20a (d-20a) (LGTM,
IFC, Pisa); Gene SilencerH (Gene Therapy Systems); lipofectamine
2000, TrizolH Reagent DNAseI amplification grade, SuperScript
II reverse transcriptase, Taq DNA polymerase, Dulbecco’s
Modified Eagle Medium-High Glucose (D-MEM-HG), fetal
bovine serum (FBS) (Invitrogen); anti-LRF (BIDMC, Boston, USA);
anti-E2F1 (sc-193) anti-p16 (sc-1661), anti-p21 (sc-397) (Santa Cruz
Biotechnology, Inc.,); anti-p19ARF (ab80) (Abcam); anti-GAPDH
(14C10) (Cell Signaling); anti-p53 (Novo Castra); T4 polynucleotide
kinase (NEB); RNeasy mini kit for isolation of total RNA from
animal cells, Polyfect, miScript System (QIAGEN); fraction V
bovine serum albumin (BSA); LightCycler 480 Probes Master,
Universal ProbeLibrary LNA Probes (Roche); X-Gal (5-bromo-4-
chloro-3-indolylb-D-galactoside); anti-a-tubulin; polybrene (Sigma);
pCMV-MCS plasmid, Herculase DNA polymerase, QuikChange
II XL Site-Directed Mutagenesis Kit (Stratagene); poly-D-Lysine
coated dish (BIOCOAT, BD); ABI PRISM 7700 Sequence
Detection System (Applied Biosystems).
Cells and culture conditions
Wt and LRF-null mouse embryonic fibroblasts (MEF) were
isolated from 13.5d mouse embryos. Briefly, embryos were
mechanically fragmented and then incubated with trypsin
(0.25% in PBS pH 7.5) at 37uC for 15–20 minutes with a
magnetic stirrer. After 10 minutes centrifugation at 2906g, pellets
were resuspended in Dulbecco’s Modified Eagle Medium+High
Glucose (DMEM-HG) without fetal bovine serum (FBS) and
centrifuged for 10 minutes at 2906g. After three washings, the cell
suspension was distributed in culture dish containing complete
DMEM-HG+10% FBS. Cells were trypsinized at confluency (p1).
The propagation protocol 3T6 (66105 cells/100 mm diameter
dish transferred every 3 days) was followed. HEK 293T and
Phoenix E cells were grown in DMEM+10% FBS. All cells were
grown at 37uC in a humidified atmosphere containing 6% CO2.
Plasmids
The entire mmu-zbtb7a 39UTR (Acc Nu NM_010731) was
obtained by PCR from genomic DNA. F (59-GAG AAG CAC
TTT AAG GAC GAG- 39) and R (59-GAT AGG AAG GCA
AAG AGC A -39) primers were used (Ta 57uC). The fragment was
cloned downstream of EGFP ORF within pEGFP-C1 plasmid and
a stop codon was inserted between the EGFP and the target
fragment, so that the transcribed mRNA is a hybrid molecule but
the translated protein is EGFP. The plasmid p-zbtb7a 39UTR was
constructed. The mutated version of this plasmid (p-zbtb7a 39UTRm)
was generated by utilizing the p-zbtb7a 39UTR as template and
modifying the miR-20a seed binding site using the QuikChange II
XL Site-Directed Mutagenesis Kit. The mutagenic primers used
were: site1 (position 2764 mRNA zbtb7a) forward 59-TCCCC-
ACTTTTTAAGT*T*AG*TTTTTAGATCG-39 and reverse 59-
GCATCTAAAAAC*TA*A*CTTAAAAAGTGGGGA-39; site2
(position 3061 mRNA Zbtb7a) forward 59-GTGGGGATCTTGG-
CAT*A*TG*GTAACTGAACGG-39 and reverse 59-CCGTT-
CAG TTAC C*AT*A*TGCCAAGATCCCCAC-39, where the
asterisks indicate the mutated bases.
Genomic fragments of about 500 bp which contained human
pri-miR-17, pri-miR-20a, pri-miR-106a, pri-miR-106b or pri-
miR-26a sequences were obtained by PCR. Primers were: F (59-
TTTGGAACTTCTGGCTATTG-39) and R (59-GGCTGCAA-
ACACAACTA-39) for pri-miR-17; F (59-AGTCGTCGGT-
CAGTCG-39) and R (59-CAAACCTGCAAAACTAACCATA-
39) for pri-miR-20a; F (59-TGAGATTGCCAGTGTTATTC-39)
and R (59-TAAGAAGTAGCCTGTGCG-39) for pri-miR-106a; F
(59-GCAGCATATGTGGAGATG-39) and R (59-TCAGCAG-
TAGGTACGGTAA-39) for pri-miR-106b; F (59-CCACTGCT-
GACCCATTCT-39) and R (59-AAGACTCCTCGTTGCCAG-
39) for pri-miR-26a. Annealing temperatures were: 54.9uC for pri-
miR-17, 54.2uC for pri-miR-20a, 57.6uC for pri-miR-106b, and
57uC for pri-miR-26a. F primers were elongated at the 59 ends to
include the GGATCC sequence and R primers were elongated at
59 ends to include the CTCGAG sequence to create BamHI and
XhoI restriction sites, respectively. The PCR products were cloned
downstream of the CMV promoter within the pCMV-MCS
plasmid. In this way, the expression plasmids nick-named p-miR-
20a, p-miR-17, p-miR-106b and p-miR-26a were obtained.
pri-miR20a was amplified by PCR from genomic human DNA
using the following primers: F 59–TATTTCCTTCAAATGAAT-
GAT-39 and R 59-TTCAGTAACAGGACAGTTTGA-39. The
sequence was then subcloned into MSCV-PIG [9] using BglII and
XhoI (PIG/miR-20a).
RT-PCR
To detect the expression of pre-miRNAs, total RNA was
extracted from MEF using the RNeasy mini kit. After DNase
treatment, 1 mg RNA was retrotranscribed using SuperScript II
reverse transcriptase. The primers were those used for cloning.
2 ml of the RT mixture was then added in 50 ml PCR reactions
and 7 ml aliquots were loaded on gel.
Northern blot
20 mg of total RNA, extracted using the Trizol reagent, were
loaded onto a 15% polyacrylamide 7 M urea gel, electrophoresed
and successively electroblotted onto Hybond N+ membrane. The
oligonucleotide used as probe was the complementary sequence of
the mature miR-20a (miRNA Registry): (59-CTACCTGCACTA-
TAAGCACTTTA-39). Probes were end-labelled with [c-32P]ATP
(300 Ci/mmole) by T4 polynucleotide kinase. Prehybridization
and hybridization were carried out in Ultrahyb Oligo solution
containing 25 mg salmon sperm DNA and 106 cpm/ml labelled
probes at 37uC overnight. Washing was performed in 66SSPE at
37uC. As a loading control, membranes were stripped and re-
hybridized with valine tRNA probe (59-GAACGTGATAAC-
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CACTACACTAC-39) or U6 probe (59-TGTGCTGCCGAAG-
CAAGCAC-39). The image of Northern hybridization signals was
obtained using a Phosphoimager (B4312 Cyclone, Packard).
EGFP reporter assay
HEK 293T cells were seeded at a density of 66105 cells per
30 mm diameter dish. 24 hours later, 140 ng of p-zbtb7a 39UTR
were cotransfected with 75–300 ng of p-miR-17, p-miR-20a, p-
miR-106 (specific miRNAs) or p-miR-26a not predicted by any
algorithm to target the 39UTR of LRF. The aspecific miRNA was
used to normalize the fluorescence values. Polyfect was used as
transfectant, according to the manufacturer’s recommendations.
36 hours after transfection fluorescence was quantitated by
cytofluorimetry (FACSCalibur, Becton Dickinson). 104 cells per
sample were analysed.
MEF transfection
Exponentially growing MEF at passage 2 were transfected with
miR-20a, d-20a, siRNA-LRF, a siRNA specific for LRF (59-
CAUAAAGAAGAGUGGGAAG-39) or si-E2F1 (Dharmacon).
Briefly, 15 ml Optimem and 25 ml transfection buffer plus 80 nM
miRNA or d-20a were mixed with a solution of Gene Silencer (5 ml)
plus Optimem (25 ml). After 15 minutes incubation, Optimem was
added up to 800 ml. Then, the transfection mixture was added to
1.26106 cells resuspended in 200 ml Optimem. After 5 min, 10 ml
Optimem was added and the suspension distributed in culture dishes
at a density of 26104 cells/cm2. After 6 hours the medium was
replaced with complete DMEM-HG. With this protocol more than
90% of MEF were transfected (data not shown). Cells were collected
at specified time points after transfection and further analyzed.
MEF retroviral infection
For retrovirus-mediated gene transfer, Phoenix E cells (36106)
were plated in a 100 mm poly-D-Lysine coated dish and, 16 hours
later, were transfected with retroviral plasmid (PIG/miR-20a) using
Lipofectamine 2000. 48 hours later, the virus-containing medium
(10 ml) was filtered, mixed with 5 ml of freshly prepared medium
and supplemented with 4 mg / ml polybrene. 76105 MEFs at
passage 2 were plated in a 100 mm dish. 16 hours later, the medium
was replaced with viral supernatant. Puromycin (2 mg /ml) was
administered 48 hours after infection. The cells were subsequently
selected for 2 days and then utilized for the various assays.
Western blot
Transfected cells grown for 48 hours in 100 mm diameter
dishes were collected, centrifuged and lysed (20 mM Tris-HCl
pH 8.0; 20 mM NaCl; 10% glycerol; 1% NP40; 10 mM EDTA;
2 mM PMSF, 2.5 mg/ml leupeptin). Infected cells were collected
immediately at the end of antibiotic selection. Proteins (30 mg/
lane) were separated on 12% SDS-polyacrylamide gel and
transferred to nitrocellulose membrane.
Immunoblotting of the membranes was performed using the
following primary antibodies: anti-LRF (1:1000); anti-E2F1
(1:1000); anti-p16 (1:250); anti-p21 (1:1000); anti-p19ARF
(1:1000); anti-p53 (1:1000); anti-a-tubulin (1:20000); anti-GAPDH
(1:10000). Signals were revealed after incubation with recom-
mended secondary antibody coupled to peroxidase by using
enhanced chemiluminescence. Scanned images were quantified
using Scion Image software.
Real-time PCR analysis
To evaluate mouse p19ARF, p21, and zbtb7a mRNA levels, total
RNA was extracted from transfected MEF using Trizol reagent
according to the manufacturer’s instructions. DNase treatment
and retrotranscription were performed as described above. Real-
time PCR was carried out using ABI PRISM 7700 Sequence
Detection System (Applied Biosystems) and LightCycler 480
(Roche). Taqman probes and oligonucleotides used were as
follows: for p19ARF, F (59-CATGGGTCGCAGGTTCTTG-39), R
(59-GCTCGCTGTCCTGGGTCTC-39) and probe (59-CACTGT-
GAGGATTCAGCGCGCG-39); for LRF, F (59-AACTACGACC-
TGAAGAACCACATG-39), R (59-AGATGGTCGGAGCGCA-
CA-39) and probe (59-CTGCGGCCATACCAGTG CGATAGC-
39); for p21, F (59-TCCACAGCGATATCCAG ACA-39), R (59-
GGACATCACCAGGATTGGAC-39) and LNA probe (59-GG-
CCCTGG-39). Relative quantitation of gene expression was
performed with the comparative CT method. GAPDH was
amplified with the following primers: F (59-GCCTTCCGTG-
TTCCTACCC-39), R (59-TGCCTGCTT CACCACCTTC-39)
and probe (59-CCTGGAGAAACCTGCCAAGTATGATGA-
CATC-39) and used as internal standard. Mature miR-20a was
quantified using the miScript System according to the manifacturer’s
instruction. Oligonucleotides 59-TAAAGTGCTTATAGTGCAG-
GTAG-39 and 59-CGCAAGGATGACACGCAAATTC-39 were
used as forward primers respectively of miR-20a and U6 in the real
time amplification mixtures. All reactions were performed in
triplicate Cellular read outs.
Cell proliferation
48 hours post-transfection, 16105 cells were seeded in a series
of 30 mm diameter dish and grown for 96 hours. At 24 hours
intervals cells were collected and counted. Growth curves after
infection were generated by seeding 2.5 104 cells per 12 well plates
in triplicate for three independent experiments. Cells were
subsequently fixed in paraformaldeyde at defined time points
and subsequently stained with cristal violet. After lysis with acetic
acid 10%, O.D. is read at 590 nm.
Senescence-associated (SA) b–galactosidase activity
48 hours post-transfection, 46104 cells were seeded in 30 mm
diameter dish and 48 hours later dishes were washed once with
PBS and fixed for 3–5 minutes at room temperature in PBS
containing 2% formaldehyde/0.2% glutaraldehyde. Cells were
then washed three times in PBS, and incubated at 37uC with
fresh SA-b–gal staining solution containing 1 mg/ml 5-bromo-4-
chloro-3-indolyl P3-D-galactoside (X-Gal) (stock = 20 mg/ml in
DMSO), 5 mM potassium ferrocyanide, 5 mM potassium
ferricyanide, 2 mM MgCl2 in PBS pH6.0. SA-b–gal positive
cells were scored after 48 hours by counting 500 cells with
normal light microscopy. For infection experiments, cells were
plated as described above (Cell Proliferation) and were scored 5
days after plating.
Binucleated cells
48 hours post-transfection, 46104 cells were seeded in 30 mm
dish and 48 hours later dishes were washed with PBS and fixed for
10 minutes with formaldehyde at room temperature. Cells were
then stained with 0.1% crystal violet/20% methanol for 15 min.
Binucleated cells were scored counting 500 cells by normal light
microscopy.
Statistical analysis
Data were analyzed using GraphPad prism (GraphPad
Software, Inc., San Diego, CA). Statistical differences were
determined by unpaired t-test, with values of P,0.05 considered
statistically significant.
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